By contrast, as mentioned earlier, the first Epogen clinical trial was performed by Drs. Eschbach and Adamson, and it was Dr. Adamson who had extensive previous preclinical experience of anemia and EPO at the University of Washington. This evidence concerns the gene EPO and anemia (phenotype).